AngioDynamics, Inc. (ANGO) Operating margin 2017–2026
AngioDynamics, Inc. (ANGO) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.5%FY2026 · since FY2017: -4.1% → -12.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -12.5% | +1.2 pp |
| FY2025 | -13.7% | +49.7 pp |
| FY2024 | -63.3% | -48.2 pp |
| FY2023 | -15.1% | -6.1 pp |
| FY2022 | -9.0% | +3.1 pp |
| FY2021 | -12.1% | +51.1 pp |
| FY2020 | -63.3% | -59.8 pp |
| FY2019 | -3.5% | +1.9 pp |
| FY2018 | -5.4% | -1.3 pp |
| FY2017 | -4.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice